Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011

Journal of Clinical Virology

Volumn 53, Issue 1, 2012, Pages 88-92

  Ann, Julie ^a   Papenburg, Jesse ^a   Bouhy, Xavier ^a   Rhéaume, Chantal ^a   Hamelin, Marie ève ^a   Boivin, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

A H3N2; Antigenic drift; Hemagglutinin; Influenza; Phylogeny

Indexed keywords

AMINO ACID SUBSTITUTION; ANTIBODY TITER; ANTIGENIC EVOLUTION; ANTIGENIC MODULATION; ANTIGENICITY; ARTICLE; CANADA; CLADISTICS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC DRIFT; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA A (H3N2); MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEASONAL VARIATION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ANTIGENS, VIRAL; EPITOPES; GENETIC DRIFT; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MUTATION; NEUTRALIZATION TESTS; PHYLOGENY; QUEBEC; SEASONS;

EID: 83355163255     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.09.016     Document Type: Article

References (12)

1. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453:615-619.
2. Kaji M., Watanabe A., Aizawa H. Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology 2003, 8:231-233.
3. Wiley D.C., Wilson I.A., Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289:373-378.
4. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990, 8:737-771.
5. Skowronski D.M., Masaro C., Kwindt T.L., Mak A., Petric M., Li Y., et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007, 25:2842-2851.
6. Tamura K., Dudley J., Nei M., Kumar S. MEGA4 molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
7. WHO manual on animal influenza diagnosis and surveillance. WHO/CDS/CSR/NCS/2002.5. p. 28-36, 48-54. (accessed 11.05.11). http://whqlibdoc.who.int/hq/2002/WHO_CDS_CSR_NCS_2002.5.pdf.
8. Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe. Influenza virus characterization. January 2010 (accessed 11.05.11). http://www.ecdc.europa.eu/en/publications/Publications/1001_Influenza_virus_characterisation_2010_JAN.pdf.
9. Public Health Agency of Canada. Weekly update on the influenza surveillance. Posted 08.01.2010. (accessed 11.05.11). http://www.phac-aspc.gc.ca/fluwatch/09-10/w51-52_09/index-fra.php.
10. Huang J.W., Yang J.M. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses. BMC Bioinform 2011, (12 (Suppl. 1)):S31.
11. Holmes E.C. RNA virus genomics: a world of possibilities. J Clin Invest 2009, 119:2488-2495.
12. GISAID EpiFlu Database. (accessed 11.05.11). http://www.gisaid.org/.